PRME
Prime Medicine, Inc.
3.00$
-0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 77.2% | 73.8% | 69.9% | 65.8% | 73.9% | 71.2% | 49.9% | 43.5% | 60.1% | 52.9% | 46.8% | 38.9% | |
| 18.4% | 21.4% | 30.2% | 21.4% | 35.5% | 61.3% | 28.0% | 19.3% | 18.5% | 18.4% | 21.8% | 19.1% | |
| 69.1% | 62.8% | 67.7% | 62.7% | 52.7% | 64.0% | 44.0% | 36.5% | 54.1% | 51.8% | 46.0% | 38.2% | |
| – | – | – | – | 16.5% | – | 0.0% | 0.0% | – | – | – | – | |
| 18.9% | 31.4% | 21.7% | 24.3% | 43.1% | 48.5% | 67.4% | 78.2% | 58.0% | 64.7% | 74.0% | 84.0% | |
| 16.5% | 29.1% | 7.8% | 8.0% | 11.4% | 12.8% | 10.4% | 12.2% | 9.1% | 10.9% | 12.3% | 12.7% | |
| 4.7% | 4.8% | 2.2% | 2.0% | 1.3% | 1.2% | 2.1% | 2.6% | 2.0% | 2.4% | 2.9% | 3.6% | |
| 5.9% | 10.1% | 3.2% | 1.8% | 1.6% | 3.8% | 3.1% | 2.3% | 2.4% | 2.6% | 4.2% | 2.3% | |
| 81.1% | 68.6% | 78.3% | 75.7% | 56.9% | 51.5% | 32.6% | 21.8% | 42.0% | 35.3% | 26.0% | 16.0% | |
| -178.0% | -253.5% | -172.5% | -228.1% | -193.8% | -231.0% | -225.2% | -283.8% | -218.8% | -259.2% | -318.1% | -393.3% | |
| 38.4% | 50.2% | 33.5% | 45.9% | 36.0% | 39.9% | 39.9% | 46.3% | 41.7% | 43.4% | 60.1% | 71.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.